ADMA

ADMA Biologics
ADMA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$5.16B
EV
$5.14B
Shares Outstanding
242.75M
Beta
0.53

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$25.74
P/E 2025E
31.84x
P/Revenue 2025E
10.43x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ADMA Biologics, Inc.

gainify
ADMA

ADMA Biologics, Inc.

ADMA

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVI...

Sector

Healthcare

Industry

Biotechnology

CEO

Grossman, Adam

Employees

685

IPO Date

2013-10-17

Headquarters

465 State Route 17, Ramsey, New Jersey, 07446, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved